Directors Dealings
Director dealings are proprietary transactions by executives, which are reportable under Art. 19 MAR. The publication of these transactions is an important contribution to the prevention of insider dealing and market manipulation. In addition, knowledge of such transactions is of great importance to the market, as these transactions provide indications of management's assessment of the company's future business prospects. The information presented here relates to companies that are under the supervision of BaFin.
Dermapharm Holding SE: A reportable insider transaction was published on 15th November 2024. The reporting obligation was triggered by a person related to Closely associated.
Transaction reporting date: 15th November 2024,
The Insider Transaction was made by Themis Beteiligungs-Aktiengesellschaft 
. The transaction toke place on 14th November 2024. . The aggregated volume was 6.464.000,00 EUR, based on an average price of 32,32 EUR. The nature of the Investment was Buy.
Dermapharm Holding SE: A reportable insider transaction was published on 29th August 2024. The reporting obligation was triggered by a person related to Closely associated.
Transaction reporting date: 29th August 2024,
The Insider Transaction was made by Themis Beteiligungs-Aktiengesellschaft . The transaction toke place on 28th August 2024. . The aggregated volume was 29.954.600,00 EUR, based on an average price of 36,53 EUR. The nature of the Investment was Buy.
Dermapharm AG: A reportable insider transaction was published on 22nd May 2024. The reporting obligation was triggered by a person related to Closely associated.
Transaction reporting date: 22nd May 2024,
The Insider Transaction was made by Themis Beteiligungs-Aktiengesellschaft . The transaction toke place on 16th May 2024. . The aggregated volume was 8.577.500,00 EUR, based on an average price of 34,31 EUR. The nature of the Investment was Buy.
Dermapharm Holding SE: A reportable insider transaction was published on 23rd November 2023. The reporting obligation was triggered by a person related to Closely associated.
Transaction reporting date: 23rd November 2023,
The Insider Transaction was made by Themis Beteiligungs-Aktiengesellschaft . The transaction toke place on 21st November 2023. . The aggregated volume was 15.216.000,00 EUR, based on an average price of 38,04 EUR. The nature of the Investment was Buy.
Dermapharm Holding SE: A reportable insider transaction was published on 13th October 2022. The reporting obligation was triggered by a person related to Closely associated.
Transaction reporting date: 13th October 2022,
The Insider Transaction was made by Themis Beteiligungs-Aktiengesellschaft . The transaction toke place on 12th October 2022. . The aggregated volume was 55.825.000,00 EUR, based on an average price of 38,50 EUR. The nature of the Investment was Buy.
Disclaimer:
The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster.
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.
If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.